Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 12/20 | 0.52 |
| ▸ | GSK3A | P49840 | 9/20 | 0.52 |
| ▸ | GSK3B | P49841 | 9/20 | 0.52 |
| ▸ | SRPK1 | Q96SB4 | 4/20 | 0.52 |
| ▸ | HIPK4 | Q8NE63 | 4/20 | 0.52 |
| ▸ | STK3 | Q13188 | 4/20 | 0.52 |
| ▸ | AURKB | Q96GD4 | 4/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.52 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.52 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.52 |
| ▸ | MAPKAPK2 | P49137 | 3/20 | 0.52 |
| ▸ | CSNK1G3 | Q9Y6M4 | 3/20 | 0.52 |
| ▸ | CDK2 | P24941 | 3/20 | 0.52 |
| ▸ | PIM3 | Q86V86 | 3/20 | 0.52 |
| ▸ | FLT3 | P36888 | 3/20 | 0.52 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.52 |
| ▸ | CLK2 | P49760 | 3/20 | 0.52 |
| ▸ | PBK | Q96KB5 | 3/20 | 0.52 |
| ▸ | PLK3 | Q9H4B4 | 2/20 | 0.52 |
| ▸ | DYRK4 | Q9NR20 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29128671 | 0.79 | CLK4 (0.53) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL21723559 | 0.79 | IDH2 (0.56) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL12506975 | 0.78 | CLK4 (0.51) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL2635287 | 0.77 | TAS2R14 (0.57) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL29128691 | 0.77 | CLK4 (0.51) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL5031654 | 0.75 | P2RX7 (0.53) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL13170010 | 0.75 | KDM4E (0.56) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL29640129 | 0.75 | P2RX7 (0.53) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL18425134 | 0.75 | ACVR1 (0.49) | CLK4GSK3AGSK3BSRPK1HIPK4 | |
| SCHEMBL10327562 | 0.75 | TAS2R14 (0.49) | CLK4GSK3AGSK3BSRPK1HIPK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190330180-A1 | PROCESS FOR THE PREPARATION OF HERBICIDAL PYRIDINYLIMIDAZOLONE COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-10-31 | — | — | US | disclosed |
| WO-2017186624-A1 | PROCESS FOR THE PREPARATION OF HERBICIDAL PYRIDINYLIMIDAZOLONE COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2017-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330180-A1 | PROCESS FOR THE PREPARATION OF HERBICIDAL PYRIDINYLIMIDAZOLONE COMPOUNDS | DDT, PDXK, CYP4F3 | CLK4 2136/4885GSK3A 2708/4885GSK3B 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.